Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vasoactol is a natural product nutritional supplement developed by the Centro Nacional de Investigaciones Científicas (CNIC) in Cuba. It is composed of a purified extract of high molecular weight alcohols derived from sugarcane wax (*Saccharum officinarum* L.). The product is primarily used as an antioxidant to prevent the oxidation of lipids and proteins by free radicals, thereby providing cardiovascular support and potentially protecting against chronic non-communicable diseases such as atherosclerosis and diabetes. It is typically administered orally in 6 mg tablet form and is recommended for middle-aged or elderly individuals, those experiencing high physical stress, or individuals with lipid metabolism alterations. Vasoactol has been commercialized in several regions, including Latin America, Europe, and Australia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vasoactol.